TreeFrog Therapeutics

French tech company | Builders Republic

About

Biotech developing cell therapies for neurological diseases using proprietary C-Stem microfluidic technology that encapsulates induced pluripotent stem cells in 3D capsules for scalable, GMP-grade production — lead program TFG-001 targeting Parkinson's disease.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Series B
Founded
2018
City
PESSAC
Region
Nouvelle Aquitaine
Legal name
TREEFROG THERAPEUTICS
SIREN
844370320
Tracked rounds
1
Amount raised
64 M€ raised since 2020

Funding rounds

  • Series B — 2021

Investors